Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy

<div>(a) Injection of TA. (b) Injection of BTXA. At 1 week, 1 month, and 3 months after completion of a treatment cycle, we observed the two groups for the effective rate of the treatment, the degree of eyelid correction, and the occurrence of complications.</div>

BioMed Research International

fig1

Figure 1

Figure 1: Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy 